Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...

Multiple myeloma may cause pain in the back, legs, hips, ribs, and stomach due to bone damage and excess calcium release. Treatments for multiple myeloma pain may range from over-the-counter and ...